Oarsman Capital, Inc. Biolife Solutions Inc Transaction History
Oarsman Capital, Inc.
- $562 Million
- Q4 2024
A detailed history of Oarsman Capital, Inc. transactions in Biolife Solutions Inc stock. As of the latest transaction made, Oarsman Capital, Inc. holds 451 shares of BLFS stock, worth $9,958. This represents 0.0% of its overall portfolio holdings.
Number of Shares
451
Previous 425
6.12%
Holding current value
$9,958
Previous $10,000
10.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding BLFS
# of Institutions
188Shares Held
47.2MCall Options Held
4.3KPut Options Held
4.7K-
Casdin Capital, LLC New York, NY8.71MShares$192 Million19.45% of portfolio
-
Black Rock Inc. New York, NY5.49MShares$121 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA3.24MShares$71.5 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.84MShares$62.6 Million0.0% of portfolio
-
Fred Alger Management, LLC New York, NY1.59MShares$35.2 Million0.21% of portfolio
About BIOLIFE SOLUTIONS INC
- Ticker BLFS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 42,684,400
- Market Cap $942M
- Description
- BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...